Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Here is a look at what DAIC viewers were reading during the month of July

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

What Viewers Were Reading in July

Here is a look at what DAIC viewers were reading during the month of July:

1. Lessons Learned from World’s First ...

August 01, 2023

The U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 Letter to Health Care Providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and Trifecta Valve with Glide Technology (GT)

News | Heart Valve Technology

FDA Issues Update on Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration

July 31, 2023 — Today, the U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 ...

July 31, 2023

AI demonstrated high accuracy, reduced non-diagnostic outputs, and identified HFpEF patients with worse outcomes.

News | Cardiovascular Clinical Studies

Study Confirms Ultromics' AI Can Improve HFpEF Detection Using a Single Echocardiogram View

July 31, 2023 — Applying AI to a single apical four chamber (A4C) view echocardiogram provides accurate information to ...

July 31, 2023

GE HealthCare is recalling malfunctioning TruSignal sensors that may reduce the amount of energy sent to the heart during defibrillation without any notification to the care provider

News | Defibrillator Monitors

GE HealthCare Recalls TruSignal SpO2 Sensors for Issues That May Reduce Defibrillation Energy, Expose Patients to Unintended Voltage, or Give Inaccurate Readings

July 28, 2023 — GE HealthCare is recalling malfunctioning TruSignal sensors that may reduce the amount of energy sent to ...

July 28, 2023

New calculator is based on precise statistical models from more than 8 million patients

News | Heart Failure

The Society of Thoracic Surgeons Launches Next-generation Adult Cardiac Surgery Risk Calculator

July 28, 2023 — The Society of Thoracic Surgeons has launched its next-generation Operative Risk Calculator to assess ...

July 28, 2023

Device manufacturers will be displaying their latest technologies at the 2023 Society of Cardiovascular Computed Tomography Annual Scientific Meeting (SCCT2023) being held in Boston from July 27 - 30.

Feature | SCCT

Innovations in Photon Counting CT, AI to be Showcased at SCCT2023

Device manufacturers will be displaying their latest technologies at the 2023 Society of Cardiovascular Computed ...

July 28, 2023

Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions for Use (IFU) do not adequately address precautions to take when treating patients who have undergone transcatheter aortic valve replacement (TAVR)

News | Stents

Abiomed Recalls All Impella Left Sided Blood Pumps for Risk of Motor Damage After Contact with Transcatheter Aortic Valve Replacement (TAVR) Stent

July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions ...

July 27, 2023

Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to be introduced into patients who have procedures with this device.

News | Left Atrial Appendage (LAA) Occluders

Abbott Recalls Amplatzer Steerable Delivery Sheath for Increased Risk of Air Embolism

July 26, 2023 — Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to ...

July 26, 2023

New U.S. patent provides intellectual property (IP) protection until December 2040, and may qualify for term extension beyond 2040

News | Hypertension

Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

July 26, 2023 — Tenax Therapeutics, Inc, a specialty pharmaceutical company focused on identifying, developing and ...

July 26, 2023

Under the agreement, BIS will initiate the US commercialization activities for ŌNŌCOR’s ŌNŌ Retrieval Device.

News | Cardiovascular Business

ŌNŌCOR signs an exclusive US distribution agreement with B. Braun Interventional Systems

July 26, 2023 —ŌNŌCOR LLC, a medical technology company dedicated to developing essential safety tools and other ...

July 26, 2023

Research shows that patients have better outcomes when they are treated at an accredited center, such as the Hypertension Center in the Smidt Heart Institute, by physicians specialized in the disease. Photo by Getty.

News | Hypertension

Smidt Heart Institute’s Hypertension Center Earns Accreditation

July 25, 2023 — The Hypertension Center in the Smidt Heart Institute at Cedars-Sinai has earned accreditation from the A ...

July 25, 2023

A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery and assistant dean for clinical trials at Weill Cornell Medicine, has been approved for a nearly $30 million funding award from the Patient-Centered Outcomes Research Institute (PCORI).

News | Cardiovascular Clinical Studies

Large PCORI Award Funds Study of Surgical Options for Coronary Artery Disease in Underrepresented Patient Populations

July 25, 2023 — A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss ...

July 25, 2023

With Only 21 Facilities Achieving this Award Nationally, AGH Ranks Among the Most Elite Mitral Valve Programs in the Country and Only Designated Center in Pennsylvania

News | Heart Valve Technology

Allegheny General Hospital Receives Recognition as a Mitral Valve Repair Reference Center from the American Heart Association and the Mitral Foundation

July 24, 2023 — Allegheny General Hospital (AGH), the flagship academic medical center of Allegheny Health Network (AHN) ...

July 24, 2023

BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, announced that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase III pivotal CardiAMP Cell Therapy Heart Failure Trial

News | Cardiovascular Clinical Studies

BioCardia Announces DSMB Recommendation to Pause New Enrollment in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial While Additional Blinded Data is Collected

July 24, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

July 24, 2023

Pilot study will assess positive impacts of real-time safety monitoring on patient outcomes and treatment experience

News | Structural Heart

Onecrea Medical Announces the Successful Completion of the First-in-human Implants of its Crea Aortic Valve

July 21, 2023 — Onecrea Medical has announced the success of the first-in-human implants of its Transcatheter Aortic ...

July 21, 2023